Market Research Logo

Injectable Drug Delivery Market: Self-injectors to Remain Fastest Growing Product Type During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

Injectable Drug Delivery Market: Self-injectors to Remain Fastest Growing Product Type During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

Report Description

This Future Market Insights (FMI) report examines the global injectable drug delivery market for the period 2018–2028. The primary objective of the report is to offer insights into market opportunity for the injectable drug delivery market.

The global injectable drug delivery market has seen substantial growth in the last decade. The market for injectable drug delivery is primarily driven by increasing prevalence of chronic diseases such as cancer, rheumatoid arthritis and diabetes. Other factors that drive the growth of the injectable drug delivery market include the need for patient-controlled delivery platforms and significant advancement in the technology. Increase in demand for point-of-care devices and the reduced dependence on healthcare provision are the other factors contributing to the growth of the injectable drug delivery market. However, stringent regulatory framework and high likelihood of premium pricing are some of the prime barriers in the growth of the injectable drug delivery market.

The Global Injectable Drug Delivery Market has been Segmented Based on:

Product Type

Usage

Distribution Channel

Regions

The report analyses the global injectable drug delivery market in terms of value. The global injectable drug delivery market report begins with the injectable drug delivery market definition and explaining different products and technologies. The injectable drug delivery market view point section includes FMI’s analysis on key trends, drivers, restraints, opportunities, trends and macro factors influencing the global injectable drug delivery market. Some of the key inclusions of injectable drug delivery report are key manufacturers and their key developments, epidemiology data and PEST analysis.

The report analyses the injectable drug delivery market based on regions and presents the forecast in terms of value for the next 10 years. The regions covered in the report include:

North America

Eastern Europe

Western Europe

Latin America

Asia Pacific except Japan (APEJ)

Japan

Middle East and Africa (MEA)

Each of these sections analyse the regional injectable drug delivery market by product type, usage, distribution channel and country. The regional introductory section provides a snapshot of the regional and segmental injectable drug delivery market shares. The intensity map of the drivers and restrains in every region helps to analyse the effective regional drivers for the injectable drug delivery market.

When developing the injectable drug delivery market forecast, the starting point is sizing the current market, which forms the base for the forecast of how the injectable drug delivery market is expected to take shape in the near future. To arrive at the current market size, we have used company share analysis for the majority of the companies. The company share analysis was executed for each of the product types separately in order to arrive at the total market value. The analysis was further broken down to country level to arrive at the total regional market size of injectable drug delivery. Given the characteristics of injectable drug delivery market, we have triangulated the outcome based on different analysis based on supply side, demand side and GDP growth rate. However, quantifying the injectable drug delivery market across aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities, rather than rationalizing them after the forecast has been completed.

The following parameters are used to estimate the injectable drug delivery market size for the base year 2017:

Country level data for GDP and health care spending

Epidemiology of main indications of injectable drug delivery

Regional trends and opportunities

The forecast presented in the global injectable drug delivery market report provides total revenue of injectable drug delivery over 2018–2028. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

In the next section of the report, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view and to access the key differentiators among the competitor firms. The market structure analysis provides tier-wise breakdown of total market revenue. The section also provides company share analysis for self-injectors market and the auto-injectors market separately. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to the market segments. Detailed profiles of players in the injectable drug delivery market are also provided in the report, which highlight company description, overview, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.

The next section of the global injectable drug delivery market report analyses the injectable drug delivery market based on product type and presents the forecast in terms of value for the next 10 years. The injectable drug delivery types covered in the report include:

Self-Injectors

Needle-free Injectors

Auto-Injectors

The next section of report analyses the market based on usage of injectable drug delivery products and provides forecast in terms of value for the next 10 years. The usages covered in this report include:

Disposable Injectors

Reusable Injectors

The next section of report analyses the market based on distribution channel of injectable drug delivery products and provides forecast in terms of value for the next 10 years. The distribution channels covered in this report include:

Hospital Pharmacies

Retail Pharmacies

E-commerce

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the products. To understand the key growth segments, Future Market Insights provides the ‘Attractiveness Index’ analysis, which helps to identify real market opportunities.


1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Injectable Drug Delivery Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Recent Developments
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
5. Global Economic Outlook
5.1. Gross Domestic Product by Region & Country, 2006 – 2021
6. Key Inclusions
6.1. Key Manufacturer List
6.2. Key Developments
6.3. PEST Analysis
7. North America Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028
7.1. Introduction
7.2. Regional Market Trends
7.3. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
7.3.1. U.S.
7.3.2. Canada
7.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
7.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
7.5.1. Self-Injectors
7.5.2. Needle free Injectors
7.5.2.1. Pre Filled Needle free injectors
7.5.2.2. Fill-Able Needle Free Injectors
7.5.3. Auto Injectors
7.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
7.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017
7.7.2. Reusable Injectors
7.7.2. Reusable Injectors
7.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028
7.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
7.9.1. Retail Pharmacies
7.9.2. Hospital pharmacies
7.9.3. E-Commerce
7.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
7.11.Drivers and Restraints: Impact Analysis
7.12.Market Attractiveness Analysis
7.12.1. By Country
7.12.2. By Product
7.12.3. By Usage
7.12.4. By Distribution Channel
7.13.Drivers and Restraints – Impact Analysis
8. Eastern Europe Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028
8.1. Introduction
8.2. Regional Market Trends
8.3. Historical Market Size (US$ Mn) By Country, 2013–2017
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Spain
8.3.5. Italy
8.3.6. Rest of Western Europe
8.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
8.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
8.5.1. Self-Injectors
8.5.2. Needle free Injectors
8.5.2.1. Pre Filled Needle free injectors
8.5.2.2. Fill-Able Needle Free Injectors
8.5.3. Auto Injectors
8.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
8.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017
8.7.1. Disposable Injectors
8.7.2. Reusable Injectors
8.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028
8.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
8.9.1. Retail Pharmacies
8.9.2. Hospital pharmacies
8.9.3. E-Commerce
8.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
8.11.Drivers and Restraints: Impact Analysis
8.12.Market Attractiveness Analysis
8.12.1. By Country
8.12.2. By Product
8.12.3. By Usage
8.12.4. By Distribution Channel
8.13. Drivers and Restraints – Impact Analysis
9. Western Europe Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028
9.1. Introduction
9.2. Regional Market Trends
9.3. Historical Market Size (US$ Mn) By Country, 2013–2017
9.3.1. Russia
9.3.2. Poland
9.3.3. Rest of Eastern Europe
9.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
9.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
9.5.1. Self-Injectors
9.5.2. Needle free Injectors
9.5.2.1. Pre Filled Needle free injectors
9.5.2.2. Fill-Able Needle Free Injectors
9.5.3. Auto Injectors
9.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
9.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017
9.7.1. Disposable Injectors
9.7.2. Reusable Injectors
9.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028
9.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
9.9.1. Retail Pharmacies
9.9.2. Hospital pharmacies
9.9.3. E-Commerce
9.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
9.11.Drivers and Restraints: Impact Analysis
9.12. Market Attractiveness Analysis
9.12.1. By Country
9.12.2. By Product
9.12.3. By Usage
9.12.4. By Distribution Channel
9.13. Drivers and Restraints – Impact Analysis
10. Latin America Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028
10.1. Introduction
10.2. Regional Market Trends
10.3. Historical Market Size (US$ Mn) By Country, 2013–2017
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4.Market Size (US$ Mn) Forecast By Country, 2018–2028
10.5.Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
10.5.1. Self-Injectors
10.5.2. Needle free Injectors
10.5.2.1. Pre Filled Needle free injectors
10.5.2.2. Fill-Able Needle Free Injectors
10.5.3. Auto Injectors
10.6.Market Size (US$ Mn) Forecast By Product Type, 2018–2028
10.7.Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017
10.7.1. Disposable Injectors
10.7.2. Reusable Injectors
10.8.Market Size (US$ Mn) Forecast By Usage Type, 2018–2028
10.9.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
10.9.1. Retail Pharmacies
10.9.2. Hospital pharmacies
10.9.3. E-Commerce
10.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
10.11. Drivers and Restraints: Impact Analysis
10.12. Market Attractiveness Analysis
10.12.1. By Country
10.12.2. By Product
10.12.3. By Usage
10.12.4. By Distribution Channel
10.13. Drivers and Restraints – Impact Analysis
11. Asia Pacific excluding Japan and China (APEJC) Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028
11.1. Introduction
11.2. Regional Market Trends
11.3. Historical Market Size (US$ Mn) By Country, 2013–2017
11.3.1. India
11.3.2. Australia and New Zealand
11.3.3. China
11.3.4. ASEAN
11.3.5. Rest of APEJ
11.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
11.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
11.5.1. Self-Injectors
11.5.2. Needle free Injectors
11.5.2.1. Pre Filled Needle free injectors
11.5.2.2. Fill-Able Needle Free Injectors
11.5.3. Auto Injectors
11.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
11.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017
11.7.1. Disposable Injectors
11.7.2. Reusable Injectors
11.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028
11.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
11.9.1. Retail Pharmacies
11.9.2. Hospital pharmacies
11.9.3. E-Commerce
11.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
11.11. Drivers and Restraints: Impact Analysis
11.12. Market Attractiveness Analysis
11.12.1. By Country
11.12.2. By Product
11.12.3. By Usage
11.12.4. By Distribution Channel
11.13. Drivers and Restraints – Impact Analysis
12. Japan Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028
12.1. Introduction
12.2. Market Trends
12.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
12.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
12.5.1. Self-Injectors
12.5.2. Needle free Injectors
12.5.2.1. Pre Filled Needle free injectors
12.5.2.2. Fill-Able Needle Free Injectors
12.5.3. Auto Injectors
12.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
12.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017
12.7.1. Disposable Injectors
12.7.2. Reusable Injectors
12.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028
12.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
12.9.1. Retail Pharmacies
12.9.2. Hospital pharmacies
12.9.3. E-Commerce
12.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
12.11. Drivers and Restraints: Impact Analysis
12.12. Market Attractiveness Analysis
12.12.1. By Product
12.12.2. By Usage
12.12.3. By Distribution Channel
12.13. Drivers and Restraints – Impact Analysis
13. MEA Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028
13.1. Introduction
13.2. Regional Market Trends
13.3. Historical Market Size (US$ Mn) By Country, 2013–2017
13.3.1. GCC Countries
13.3.2. South Africa
13.3.3. Rest of MEA
13.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
13.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
13.5.1. Self-Injectors
13.5.2. Needle free Injectors
13.5.2.1. Pre Filled Needle free injectors
13.5.2.2. Fill-Able Needle Free Injectors
13.5.3. Auto Injectors
13.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
13.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017
13.7.1. Disposable Injectors
13.7.2. Reusable Injectors
13.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028
13.9.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
13.9.1. Retail Pharmacies
13.9.2. Hospital pharmacies
13.9.3. E-Commerce
13.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
13.11. Drivers and Restraints: Impact Analysis
13.12. Market Attractiveness Analysis
13.12.1. By Country
13.12.2. By Product
13.12.3. By Usage
13.12.4. By Distribution Channel
13.13. Drivers and Restraints – Impact Analysis
14. Forecast Factors: Relevance and Impact
15. Forecast Assumptions
16. Competition Analysis
16.1. Competition Dashboard
16.2. Market Share & Structure Analysis
16.3. Company Deep Dive
16.3.1. Amgen Inc.
16.3.1.1. Overview
16.3.1.2. Product and Usage Portfolio
16.3.1.3. Production Footprint
16.3.1.4. Sales Footprint
16.3.1.5. Channel Footprint
16.3.1.6. Strategy
16.3.1.6.1. Marketing Strategy
16.3.1.6.2. Product Strategy
16.3.1.6.3. Channel Strategy
16.3.2. Antares Pharma Inc.
16.3.2.1. Overview
16.3.2.2. Product and Usage Portfolio
16.3.2.3. Production Footprint
16.3.2.4. Sales Footprint
16.3.2.5. Channel Footprint
16.3.2.6. Strategy
16.3.2.6.1. Marketing Strategy
16.3.2.6.2. Product Strategy
16.3.2.6.3. Channel Strategy
16.3.3. Becton, Dickinson and Company
16.3.3.1. Overview
16.3.3.2. Product and Usage Portfolio
16.3.3.3. Production Footprint
16.3.3.4. Sales Footprint
16.3.3.5. Channel Footprint
16.3.3.6. Strategy
16.3.3.6.1. Marketing Strategy
16.3.3.6.2. Product Strategy
16.3.3.6.3. Channel Strategy
16.3.4. Consort Medical Plc (Bespak)
16.3.4.1. Overview
16.3.4.2. Product and Usage Portfolio
16.3.4.3. Production Footprint
16.3.4.4. Sales Footprint
16.3.4.5. Channel Footprint
16.3.4.6. Strategy
16.3.4.6.1. Marketing Strategy
16.3.4.6.2. Product Strategy
16.3.4.6.3. Channel Strategy
16.3.5. Crossjet
16.3.5.1. Overview
16.3.5.2. Product and Usage Portfolio
16.3.5.3. Production Footprint
16.3.5.4. Sales Footprint
16.3.5.5. Channel Footprint
16.3.5.6. Strategy
16.3.5.6.1. Marketing Strategy
16.3.5.6.2. Product Strategy
16.3.5.6.3. Channel Strategy
16.3.6. Medtronic plc
16.3.6. Overview
16.3.6.2. Product and Usage Portfolio
16.3.6.3. Production Footprint
16.3.6.4. Sales Footprint
16.3.6.5. Channel Footprint
16.3.6.6. Strategy
16.3.6.6.1. Marketing Strategy
16.3.6.6.2. Product Strategy
16.3.6.6.3. Channel Strategy
16.3.7. Mylan N.V.
16.3.7.1. Overview
16.3.7.2. Product and Usage Portfolio
16.3.7.3. Production Footprint
16.3.7.4. Sales Footprint
16.3.7.5. Channel Footprint
16.3.7.6. Strategy
16.3.7.6.1. Marketing Strategy
16.3.7.6.2. Product Strategy
16.3.7.6.3. Channel Strategy
16.3.8. SHL Group
16.3.8.1. Overview
16.3.8.2. Product and Usage Portfolio
16.3.8.3. Production Footprint
16.3.8.4. Sales Footprint
16.3.8.5. Channel Footprint
16.3.8.6. Strategy
16.3.8.6.1. Marketing Strategy
16.3.8.6.2. Product Strategy
16.3.8.6.3. Channel Strategy
16.3.9. West Pharmaceutical Services
16.3.9.1. Overview
16.3.9.2. Product and Usage Portfolio
16.3.9.3. Production Footprint
16.3.9.4. Sales Footprint
16.3.9.5. Channel Footprint
16.3.9.6. Strategy
16.3.9.6.1. Marketing Strategy
16.3.9.6.2. Product Strategy
16.3.9.6.3. Channel Strategy
16.3.10. Ypsomed
16.3.10.1. Overview
16.3.10.2. Product and Usage Portfolio
16.3.10.3. Production Footprint
16.3.10.4. Sales Footprint
16.3.10.5. Channel Footprint
16.3.10.6. Strategy
16.3.10.6.1. Marketing Strategy
16.3.10.6.2. Product Strategy
16.3.10.6.3. Channel Strategy
17. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Region
17.1.Introduction / Key Findings
17.2.Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017
17.2.1. North America
17.2.2. Western Europe
17.2.3. Eastern Europe
17.2.4. Latin America
17.2.5. Asia Pacific excluding Japan
17.2.6. Japan
17.2.7. Middle East and Africa
17.3. Market Size (US$ Mn) Forecast By Region, 2018–2028
17.4.Market Attractiveness Analysis By Region
18. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Product
18.1. Introduction
18.2.Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
18.2.1. Self-Injectors
18.2.2. Needle-free Injectors
18.2.3. Auto-Injectors
18.3. Market Size (US$ Mn) Forecast By Product Type, 2018–2028
18.4.Market Attractiveness Analysis By Product Type
19. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Usage
19.1. Introduction
19.2.Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017
19.2.1. Disposable Injectors
19.2.2. Reusable Injectors
19.3. Market Size (US$ Mn) Forecast By Usage, 2018–2028
19.4.Market Attractiveness Analysis By Usage
20. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
20.1. Introduction
20.2.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
20.2.1. Retail Pharmacies
20.2.2. Hospital Pharmacies
20.2.3. E-commerce
20.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028
20.4.Market Attractiveness Analysis By Distribution Channel
21. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028
21.1.Market Value Share Analysis
21.1.1. By Country
21.1.2. By Product
21.1.3. By Usage
21.1.5. By Distribution Channel
21.2.Y-o-Y Growth Analysis
21.2.1. By Country
21.2.2. By Product
21.2.3. By Usage
21.2.5. By Distribution Channel
21.3. Absolute $ Opportunity

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report